Journal ArticleOPEN ACCESS

Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)

  • Mahdi H
  • Hafez N
  • Doroshow D
  • et al.
JCO Precision Oncology (2021) (5) 1432-1442
DOI: 10.1200/po.20.00439
69Citations
Citations of this article
54Readers
Mendeley users who have this article in their library.

Abstract

PURPOSEPoly (ADP-ribose) polymerase (PARP) inhibitors have emerged as promising therapy in cancers with homologous recombination repair deficiency. However, efficacy is limited by both intrinsic an...

Cite

CITATION STYLE

APA

Mahdi, H., Hafez, N., Doroshow, D., Sohal, D., Keedy, V., Do, K. T., … Eder, J. P. (2021). Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). JCO Precision Oncology, (5), 1432–1442. https://doi.org/10.1200/po.20.00439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free